13D Filing: Aisling Capital III LP and Transenterix Inc. (TRXC)

Page 5 of 12

Page 5 of 12 – SEC Filing

CUSIP No. 89366M102
SCHEDULE 13D/A
Page 5 of 12

1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Steve Elms
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3
SEC USE ONLY
4
SOURCE OF FUNDS
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
-0-
8
SHARED VOTING POWER
11,490,831
9
SOLE DISPOSITIVE POWER
-0-
10
SHARED DISPOSITIVE POWER
11,490,831
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,490,831
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.8%
14
TYPE OF REPORTING PERSON
IN

Follow Asensus Surgical Inc. (NYSEMKT:ASXC)

Page 5 of 12